about
Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2pSiderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy.Micafungin use in children.Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran.Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patients.Increased mortality in young candidemia patients associated with presence of a Candida albicans general-purpose genotype.Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropeniaInvasive fungal disease in PICU: epidemiology and risk factors.Clinical features and risk factors for blood stream infections of Candida in neonates.Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in childrenInvasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients.Unexpected genomic variability in clinical and environmental strains of the pathogenic yeast Candida parapsilosisComparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.Fungal infections in pediatric intensive care units.Candida infections in non-neutropenic children after the neonatal period.Antifungal therapy in children: an update.Role of probiotics in prevention of Candida infection in critically ill children.Antifungal agents in current pediatric practice.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Risk factors for candidemia in pediatric intensive care unit patients.Microbial epidemiology of candidemia in neonatal and pediatric intensive care units at Children's Medical Center, Tehran.Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes.Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries.Tissue distribution of anidulafungin in neonatal rats.Caspofungin resistant disseminated candidiasis in a 7-year-old girl with T cell lymphoma: a case report.The Frequency of Infective Endocarditis in Candida Bloodstream Infections: a Retrospective Study in a Child Hospital.Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.Candidemia in Febrile Neutropenic Patients; a Brief Report.
P2860
Q28484616-E717BF49-5987-49AA-BE4B-344FB1ADED42Q30243906-2EE70EE5-9EB3-4A1E-969C-E3BFADC109BBQ33397111-2CDBA92A-7315-4FF5-93BC-63A78F6761C4Q33851272-05561A98-42BF-4543-BD6F-8114315D9E19Q34932330-7000A312-4068-414C-9338-D48571434AA9Q35192242-1BD6981D-DDEF-4D54-AE49-9392DED321EAQ35589175-47688602-94B3-463D-878F-53A3D9B4784BQ35835858-9D36A5C2-3874-4B44-AA9E-1FDB39EFB084Q35942881-EDB9D879-50B8-4F56-841B-726DB10BA9F9Q35973408-B9CB49A0-6769-4A9D-82A7-02905935D9EBQ36237993-96D8AD78-8875-4142-B2BD-E085738112C9Q36838766-4C5035CE-7E33-471A-87A3-121E23E459F7Q37430063-0E01C2F9-1688-4DAB-B0AD-45C334DBCCACQ37636223-0494312A-A3CE-4D80-AC18-B41B24DE9D64Q37900308-9FF33DAC-902A-4553-B027-A39BB7BE48D0Q37942655-8E35C518-4646-4015-B9FF-0355F913E510Q38015090-A05E4A7D-545C-4E30-A1CB-25C58AFE49E6Q38061943-B7ECDF9E-3634-4E9E-AB12-BCE23C23C33EQ38101520-26152478-1236-4EA4-932B-381DEDFE7EE9Q38353420-DEAB93F0-D951-4AAA-ACFE-F2E98C09607CQ39232717-6CAA804D-FA0C-4DD9-8478-04BE48EAB4BBQ40057634-96445BE9-4A88-420A-A0B9-6C747E04DBFAQ40309090-17EF412C-F9A0-4262-8387-63405EE54A9BQ40517272-2DD7263E-AECB-474A-9944-901C9ED3BF0CQ41929675-68B87F4F-5EDD-4A62-AB14-B74DB54CA1C4Q43425305-88068025-6141-4E3D-838C-F563B625DF8CQ47646997-B0152E58-13CB-47B2-B849-77FC05F3DB7EQ48163160-B94FBC0E-216C-468C-BA62-EBD8A7AA3249Q48670237-4A24D7C1-4E4F-4041-A528-CF249A7EF322Q50021448-CC4E0D7D-E4A3-46F6-81C8-0F85833F026BQ54242110-9F7695CF-1B1C-4BEF-8958-667CA9E1FA66Q54943425-3189126C-8B10-4A1F-B5AD-BE02800F23C6Q55648234-4333D750-0773-46C3-80C2-ACFE3CECE7E4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Candidemia in children.
@en
Candidemia in children.
@nl
type
label
Candidemia in children.
@en
Candidemia in children.
@nl
prefLabel
Candidemia in children.
@en
Candidemia in children.
@nl
P1476
Candidemia in children.
@en
P2093
Theoklis Zaoutis
P304
P356
10.1185/03007995.2010.487796
P407
P577
2010-07-01T00:00:00Z